How is anti-thrombotic therapy managed surrounding left-sided endocardial ablation in patients without other indications for anti-thrombotic therapy?
There is high variability in the management of anti-thrombotic therapy for left-sided endocardial ablations in patients without other indications, highlighting the need for further studies to determine the safest approach.
Our survey indicates that the management of anti-thrombotic therapy surrounding left-sided endocardial ablation of patients without other indications for anti-thrombotic therapy is highly variable. Further studies are necessary to evaluate the safest approach to these procedures.
Nesti et al. (2023) studied this question.